You are here

Practice Management


Women who survived an MI or ischemic stroke early in their lives had higher mortality rates and fatal and nonfatal cardiovascular events later in their lives compared with a control group, according to a long-term follow-up study.


Recent Headlines

FDA issues safety alert for coating issues on catheters, guidewires and other devices

The FDA issued a safety alert on Nov. 23 warning of potential issues with coatings peeling or flaking off of intravascular catheters, guidewires, balloon angioplasty catheters, delivery sheaths, implant delivery systems and other medical devices.

AMA votes to ban direct-to-consumer advertising of prescription drugs and medical devices

Physicians at an American Medical Association (AMA) meeting in Atlanta voted on Nov. 17 to support a ban of direct-to-consumer advertising of prescription medications and medical devices.

Nearly 30 percent of U.S. adults have hypertension

From 2011 to 2014, the prevalence of hypertension among adults in the U.S. was 29 percent, including 30 percent among men and 28.1 percent among women. However, only 53 percent of adults with hypertension had their high blood pressure under control.

AHA.15: Peer-group intervention strategy reduces cardiovascular risk factors

For adults with cardiovascular disease risk factors, a peer-group intervention strategy helped them reduce their blood pressure, improve their exercise, lose weight and quit smoking, according to a randomized, multicenter study in Spain.

Will SPRINT trial results change practice?

After the full results of the SPRINT study were presented on Nov. 9 at the American Heart Association Scientific Sessions and simultaneously published online in the New England Journal of Medicine, the question remains whether they will change practice.

AHA.15: Shared financial incentives lead to LDL cholesterol reductions

Patients and primary care physicians who had shared financial incentives achieved significant reductions in low-density lipoprotein (LDL) cholesterol, according to a cluster randomized trial. However, the initiative to lower LDL cholesterol did not work if patients or physicians could not share the money.

AHA.15: Results of SPRINT trial may change systolic blood pressure target goals

The release of the full results of the SPRINT (Systolic Blood Pressure Intervention Trial) study on Nov. 9 may lead cardiologists to re-consider the ideal blood pressure goals for some patients.

AHA.15: SPRINT trial finds lowering systolic blood pressure target improves outcomes

For adults who were at least 50, had an increased risk of cardiovascular events and did not have diabetes, reducing the systolic blood pressure target to less than 120 mm Hg led to lower rates of fatal and nonfatal major cardiovascular events and death from any cause compared with the standard target of less than 140 mm Hg.

AHA.15: Female cardiologists earn less than male colleagues

Female cardiologists earned $31,749 less than expected in 2013, according to researchers who analyzed salary data and used a Peters-Belson technique and multivariate regression analysis.

FDA finds clopidogrel does not increase or decrease the risk of death in patients with heart disease

After an extensive review, the FDA found that the long-term use of clopidogrel does not increase or decrease the overall risk of death in patients with or at risk for heart disease. The FDA, which released its findings on Nov. 6, also said clopidogrel does not increase or decrease the risk of cancer or death from cancer.